NCT04065399 2026-03-18
AUGMENT-101
Syndax Pharmaceuticals
Phase 1/2 Recruiting
Clinical Trials
10 trialsNCT04634552 2026-03-17
MonumenTAL-1
Janssen Research & Development, LLC
Phase 2 Recruiting
NCT03145181 2026-03-12
MajesTEC-1
Janssen Research & Development, LLC
Phase 1/2 Active not recruiting
NCT03399799 2026-03-12
MonumenTAL-1
Janssen Research & Development, LLC
Phase 1 Active not recruiting
NCT04557098 2026-03-12
MajesTEC-1
Janssen Research & Development, LLC
Phase 2 Active not recruiting
NCT04971226 2026-03-10
A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
Novartis
Phase 3 Active not recruiting
NCT03336333 2026-03-09
SEQUOIA
BeOne Medicines
Phase 3 Active not recruiting
NCT03625037 2026-03-03
EPCOREâ„¢ NHL-1
Genmab
Phase 1/2 Active not recruiting
NCT02730299 2026-02-25
Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS
Gamida Cell ltd
Phase 3 Completed
NCT02981628 2026-02-23
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
Children's Oncology Group
Phase 2 Recruiting